Evolent Health (EVH) Gains from Investment Securities (2016 - 2025)

Evolent Health has reported Gains from Investment Securities for 10 years, with the latest figure at $4.7 million in Q4 2025.

• On a quarterly basis, Gains from Investment Securities rose 210.9% year-over-year to $4.7 million in Q4 2025; TTM through Jun 2026 was $3.6 million, a 432.31% increase from a year earlier, with the FY2025 full-year figure at $6.5 million, up 32.33% from the prior year.
• Gains from Investment Securities was $4.7 million for Q4 2025 at Evolent Health, up from -$1.1 million in the prior quarter.
• The five-year high for Gains from Investment Securities was $14.1 million in Q4 2021, with the low at -$17.7 million in Q4 2022.
• Average Gains from Investment Securities over 5 years is $1.1 million, with a median of $500000.0 recorded in 2022.
• The largest YoY upside for Gains from Investment Securities was 1123.23% in 2022 against a maximum downside of 5544.44% in 2022.
• Over 5 years, Gains from Investment Securities stood at $14.1 million in 2021, then sank by 225.53% to -$17.7 million in 2022, then jumped by 133.54% to $5.9 million in 2023, then sank by 170.74% to -$4.2 million in 2024, then surged by 210.9% to $4.7 million in 2025.
• The last three Gains from Investment Securities figures came in at $4.7 million (Q4 2025), -$1.1 million (Q3 2025), and $3.2 million (Q2 2025), per Business Quant data.